LEIDOS BIOMEDICAL RESEARCH, INC.
NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity
NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity is a funding opportunity from LEIDOS BIOMEDICAL RESEARCH, INC., up to 25131, closing August 30, 2026.
Aug 30, 2026
(30d left)Overview
Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity Chronic obstructive pulmonary disease (COPD) is increasing worldwide and soon will surpass the global burden of infectious diseases as a cause of morbidity and mortality worldwide. Despite the enormous clinical burden of COPD, specific treatments…